Skip to main content

Sienna Biopharmaceuticals, Inc., is a medical dermatology and aesthetics company focused on developing safe and effective targeted therapies to treat inflammatory skin conditions and aesthetic concerns that impact the health and appearance of patients.

Recent News

Sienna Biopharmaceuticals Announces $40 Million Series B Financing

Topical Biotech Innovation in Medical Dermatology and Aesthetics   Westlake Village, CA, April 24, 2017 – Sienna Biopharmaceuticals, Inc., a privately held, clinical stage medical dermatology and aesthetics company, today announced that it completed a $40 million Series B financing led by existing investors ARCH Venture Partners and Venvest Capital. Additional investors participating included Partner ... Read more »